Description
| Product Name | CAT.No | Size |
| FACTOR II ASSAY KIT | COAG129A | 5 x 1ml; 1 x 60ml |
| FACTOR IX ASSAY KIT | COAG127A | 5 x 1ml; 1 x 60ml |
| FACTOR V ASSAY KIT | COAG128A | 5 x 1ml; 1 x 60ml |
| FACTOR VII ASSAY KIT | COAG124A | 5 x 1ml; 1 x 60ml |
| FACTOR VIII ASSAY KIT | COAG122A | 5 x 1ml; 1 x 60ml |
| FACTOR X ASSAY KIT | COAG123A | 5 x 1ml; 1 x 60ml |
| FACTOR XI ASSAY KIT | COAG133A | 5 x 1ml; 1 x 60ml |
| FACTOR XII ASSAY KIT | COAG126A | 5 x 1ml; 1 x 60ml |
Product Description
The Biorex Diagnostics Factor Deficient Substrate Plasma Assays are in vitro diagnostic tools for the quantitative determination of specific coagulation factors in patients with suspected congenital or acquired blood clotting deficiencies. These assays provide reliable data to support accurate diagnosis, treatment planning, and monitoring of haemostatic disorders in clinical laboratories and hospital settings.
Key Features
• Quantitative measurement – precise determination of individual coagulation factors
• Sensitive and specific – detects congenital and acquired factor deficiencies
• Versatile use – suitable for multiple factors including II, V, VII, VIII, IX, X, XI, XII, XIII
• Supports clinical decision-making – guides diagnosis and treatment of bleeding disorders
• Reliable and reproducible – consistent results under stringent quality standards
Benefits
The Biorex Factor Assays enable accurate assessment of coagulation factor activity, assisting clinicians in diagnosing factor deficiencies, monitoring therapy, and tailoring patient management. Their quantitative, sensitive, and versatile design ensures effective haemostasis evaluation, contributing to improved outcomes in patients with bleeding or clotting disorders.